Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Women’s health at FDA

This article was originally published in The Gray Sheet

Executive Summary

Drug center scientist Kathleen Uhl will become director of FDA's Office of Women's Health in mid-December, the agency announces Nov. 21. Theresa Toigo has served as acting head since Sept. 16 to fill a hole left by Susan Wood, who resigned in protest over the agency's handling of Barr's Plan B emergency contraceptive pill (1"The Gray Sheet" Sept. 5, 2005, p. 6)...
Advertisement

Related Content

FDA Women’s Health Director Susan Wood Resigns In Protest Over Plan B
FDA Women’s Health Director Susan Wood Resigns In Protest Over Plan B
Advertisement
UsernamePublicRestriction

Register

MT022961

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel